1. ALLA AKTIER
  2. NYHETER
  3. ASCELIA PHARMA

Ascelia Pharma

Nyheter Ascelia Pharma Nyheter alla bolag

Change in Number of Shares and Votes in Ascelia Pharma AB

LHFI

During the month of November, the number of shares and votes in Ascelia Pharma AB have changed due to conversion of a total of 26,310 series C shares into a total of 26,310 ordinary shares for delivery of shares to participants in the performance-based share saving program that was adopted by the annual general meeting held on 5 May 2021 (LTI 2021).

As of 29 November 2024, the number of shares in Ascelia Pharma AB amounts to 97,193,153 shares, of which 96,106,032 are ordinary shares with one vote each and 1,087,121 are series C shares with 1/10 vote each. The total number of votes in the company amounts to 96,214,744.1.

About us

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. The company has two drug candidates – Orviglance and Oncoral – in clinical development. Ascelia Pharma has global headquarters in Malmö, Sweden, and is listed on Nasdaq Stockholm (ticker: ACE). For more information, please visit http://www.ascelia.com.

Contacts

Magnus Corfitzen, CEO
Email: moc@ascelia.com
Tel: +46 735 179 118

Julie Waras Brogren, Deputy CEO (Finance, Investor Relations & Commercial)
Email: jwb@ascelia.com
Tel: +46 735 179 116

This information was submitted for publication, through the agency of the contact persons set out above.

This information is information that Ascelia Pharma is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2024-11-29 11:40 CET.

Attachments

Change in Number of Shares and Votes in Ascelia Pharma AB

Datum 2024-11-29, kl 11:40
Källa MFN
Bifogade filer
Change in Number of Shares and Votes in Ascelia Pharma AB
Affiliate
Kom igång med ditt sparande på bara några minuter! Hos Avanza handlar du aktier från 0 kr på Stockholmsbörsen och får tillbaka alla fondavgifter (ja, alla!) upp till 50 000 kr i samlat sparande. Kanske är det därför Avanza har Sveriges nöjdaste sparare 15 år i rad.
Investeringar innebär en risk